Leiden University Scholarly Publications

Groot, S. de; Pijl, H.; Charehbili, A.; Ven, S. van de; Smit, V.T.H.B.M.; Meershoek-Klein Kranenbarg, E.; ... ; Dutch Breast Canc Res Grp 2019

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)

Article / Letter to editor

metadata only

Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Putter, H.; Kranenbarg, E.M.K.; Kroep, J.R.; ... ; Velde, C.J.H. van de 2017

Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)

Article / Letter to editor

metadata only

Kroep, J.R.; Charehbili, A.; Coleman, R.E.; Aft, R.L.; Hasegawa, Y.; Winter, M.C.; ... ; Kohno, N. 2016

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

Article / Letter to editor

metadata only

Charehbili, A. 2015

Optimising preoperative systemic therapy for breast cancer

Doctoral Thesis

some documents under embargo

2017-03-16T00:00:00Z; 2017-03-16T00:00:00Z; 2017-03-16T00:00:00Z

This thesis was divided in two parts. Part I demonstrated benefit of zoledronic acid addition to chemotherapy in terms of pathological response in postmenopausal women. Part II is all about... Show moreThis thesis was divided in two parts. Part I demonstrated benefit of zoledronic acid addition to chemotherapy in terms of pathological response in postmenopausal women. Part II is all about neoadjuvant endocrine therapy, and discusses the optimal duration of this treatment and the information on treatment efficacy that aromatase-inhibitor specific adverse events may provide. Show less

Engels, C.C.; Charehbili, A.; Velde, C.J.H. van de; Bastiaannet, E.; Sajet, A.; Putter, H.; ... ; Kuppen, P.J.K. 2015

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

Article / Letter to editor

metadata only

Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Kranenbarg, E.M.K.; Kroep, J.R.; Putter, H.; ... ; Velde, C.J.H. van de 2014

Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial

Article / Letter to editor

metadata only